Medicine

Cancer Cure Just One Year Away, Scientists Claim

Cancer Cure Just One Year Away, Scientists Claim

For all the Israel-haters out there, they'd better hope that that Israelis are forgiving if they are stricken with cancer, because if a new report out of Israel turns out to be true, scientists in the Jewish state have discovered a cure.

"We believe we will offer in a year's time a complete cure for cancer", said Dan Aridor, chairman of the company's board.

"We believe we will offer in a year's time a complete cure for cancer", Aridor told the paper.

Aridor, meanwhile, said it will work from "Day 1" and will cause "no or minimal side effects at a much lower cost than most other treatments".

Accelerated Evolution Biotechnologies (AEBi) claims to use peptides, a chain of amino acids, to target and kill cancer cells.

That translates to about 2.6 million fewer cancer deaths total than would have been expected if death rates stayed at their peak, which was seen in 1991, according to the study. Specific drugs will be given to patients based on their type of cancer, the report said.

More news: Apple Pulls FaceTime Group Calling Over Microphone Eavesdropping

"It is not really fair for them to announce something like this without really properly vetting it, without peer-reviewed publications or with a clinical trial", said Moffit Cancer Center researcher Vince Luca.

"The probability of having multiple mutations that would modify all the targeted receptors decreases dramatically with the number of targets used", Morad continued.

CEO Ilan Morad told the Jerusalem Post that AEBi has only finished its first exploratory mice experiment, which he claims inhibited cancer cell growth. "Our solution will be both generic and personal". "Instead of attacking receptors one at a time, we attack receptors three at a time - not even cancer can mutate three receptors at the same time".

"If it does not completely annihilate the cancer, the remaining cells can start to get mutations again, and then the cancer comes back, but this time it is drug resistant", Morad said.

AEBi is about to begin clinical trials that will wrap up in a few years.

An Israeli biotech company said preliminary research on mice gives it hope of developing a cancer cure "within a year's time" - but it still has years of testing ahead of it before it could get USA approval - even if it works for humans. That means cancer patients can give a biopsy to the lab.